Medicines Safety: A Systems Approach to Reducing Harm

Why this topic matters

Medication errors are recognised globally as a major patient safety challenge. The World Health Organization (WHO) has highlighted medication safety as a key area for action, aiming to reduce severe avoidable medication-related harm by 50% globally over five years. In the UK, NHS England’s National Patient Safety Strategy identifies medicines safety as a priority, acknowledging that medication errors can lead to prolonged hospital stays, increased healthcare costs, and, tragically, patient death.

Focusing on individuals rather than systems can lead to a 'blame culture' that discourages reporting and learning. Clinicians, particularly those in high-pressure environments, are susceptible to human error. A systems approach acknowledges this inherent human fallibility and seeks to build safeguards, checks, and resilient processes that minimise the likelihood of error reaching the patient, and mitigate the impact when it does occur. This proactive stance is essential for creating a safer environment for both patients and staff.

Practical explanation

A systems approach to medicines safety views adverse events not as isolated incidents caused by individual negligence, but as symptoms of underlying weaknesses in processes, organisational structures, technology, or culture. This perspective draws heavily from principles of human factors and safety science.

Key elements of a systems approach include:

• Acknowledging human factors: Recognising the impact of fatigue, workload, distractions, and cognitive biases on decision-making and performance.
• Process Redesign: Streamlining workflows, standardising practices, and introducing clear protocols for high-risk activities (e.g., prescribing, dispensing, administration).
• Technological Solutions: Implementing electronic prescribing and medication administration (ePrescribing/eMAR), clinical decision support systems, barcode scanning, and smart pumps to reduce manual errors.
• Communication & Teamwork: Enhancing communication channels between multidisciplinary teams (doctors, nurses, pharmacists, allied health professionals) during transitions of care, handovers, and in critical situations.
• Culture of Safety: Fostering an environment where staff feel safe to report incidents, voice concerns, and participate in incident analysis without fear of unfair blame.
• Learning from Incidents: Moving beyond punitive responses to comprehensive root cause analysis (RCA) or similar methodologies (such as Systems Approach to Safety Investigation), identifying 'latent conditions' and implementing system-wide changes.
• Proactive Risk Assessment: Using tools like Failure Mode and Effects Analysis (FMEA) to identify potential failure points in a process before they lead to patient harm.

Common pitfalls

Despite the clear benefits, implementing a systems approach can encounter several challenges:

• Blame Culture Persistence: Overcoming ingrained habits of individual blame, especially after serious incidents, requires sustained leadership commitment and cultural change.
• Under-resourcing: Implementing technological solutions, training staff, and dedicating time to process analysis requires significant resources, which can be a barrier in fiscally constrained NHS environments.
• Complexity of Systems: Healthcare systems are incredibly complex and interconnected. An intervention in one area might have unintended consequences elsewhere, necessitating careful planning and evaluation.
• Lack of Stakeholder Engagement: Without genuine buy-in from all professional groups and leadership, system changes may be resisted or implemented half-heartedly.
• Fixation on Reactive Measures: A tendency to focus solely on addressing reported incidents rather than proactively identifying and mitigating potential risks.
• Insufficient Data Analysis: Not effectively collecting, analysing, and acting upon data from incident reports, audits, and safety alerts to inform systemic improvements.

Step-by-step approach to improving medicines safety through a systems lens

Adopting a systems approach for medicines safety is an iterative process. Here’s a pragmatic framework:

1. Establish a clear governance structure and leadership commitment

Form a multidisciplinary medicines safety group, with representation from medical, nursing, pharmacy, and management. Ensure clear leadership support and resources are allocated.

2. Understand your current system and identify high-risk areas

• Data Collection: Analyse existing incident reports (e.g., from local risk management systems, national reporting systems). Look for patterns, common error types, and contributing factors.
• Process Mapping: Map out key medication processes (e.g., prescribing, dispensing, administration, monitoring, reconciliation). Identify steps where errors are most likely to occur.
• Risk Assessment: Conduct proactive risk assessments (e.g., FMEAs) on new processes or known high-risk areas (e.g., high-alert medications, transitions of care).

3. Diagnose the root causes (beyond individual error)

When an incident occurs, use analytical tools such as Root Cause Analysis (RCA) or the Systems Approach to Safety Investigation (SASI) framework. Focus on:

• Latent conditions: Underlying organisational, environmental, or process flaws.
• Active failures: The immediate errors, but always in the context of the latent conditions.
• Contributing factors: Gaps in knowledge, training, communication, staffing, equipment, or environmental factors.

4. Design and implement system-level interventions

Based on your diagnosis, develop interventions that address the systemic root causes. Examples include:

• Standardisation: Developing clear guidelines, order sets, protocols, and pathways.
• Simplification: Reducing unnecessary steps in processes.
• Automation/Technologies: Implementing ePrescribing, barcode scanning, automated dispensing cabinets.
• Forcing Functions/Constraints: Designing systems to prevent unsafe actions (e.g., medication libraries on smart pumps).
• Training and Education: Focussing on specific weak points identified, incorporating human factors principles.
• Environmental Changes: Improving lighting, reducing noise, optimising workspace layout.
• Communication Strategies: Structured handovers (e.g., SBAR), multidisciplinary ward rounds.

5. Evaluate and monitor the impact

Measure the effectiveness of your interventions. This involves:

• Outcome Measures: Tracking rates of medication errors, adverse drug events, patient harm.
• Process Measures: Monitoring compliance with new protocols, usage of new technologies.
• Balancing Measures: Ensuring the changes haven't inadvertently created new problems or worsened other aspects of care.
• Feedback Loops: Regularly review incident data, conduct safety walk-rounds, and gather staff feedback to identify further areas for improvement.

6. Foster a culture of continuous learning and improvement

Regularly review and update safety processes. Share lessons learned transparently across the organisation. Encourage staff at all levels to contribute to safety improvements.

Example in clinical practice: Implementing ePrescribing to reduce prescribing errors

Imagine a hospital identifies a high rate of prescribing errors, particularly related to legibility, drug-drug interactions, and incorrect dosages for paediatric patients on paper charts.

Systems Approach: Instead of blaming individual doctors, the hospital's medicines safety group (pharmacists, doctors, nurses, IT specialists) undertakes a comprehensive review. They identify latent conditions such as high workload, lack of immediate access to patient history/allergies, fragmented decision support, and the inherent risks of manual transcription.

Intervention: They decide to implement a phased rollout of a new electronic prescribing and medication administration (ePrescribing/eMAR) system.

• Design: The system is configured with mandatory fields, allergy alerts, drug-drug interaction warnings, dose range checking (especially for paediatric patients), and pre-populated order sets for common conditions.
• Implementation: Extensive training is provided to all prescribers, pharmacists, and nurses. Super-users are identified and available for immediate support. A dedicated project team monitors the rollout carefully.
• Monitoring & Evaluation: The team tracks metrics like prescribing error rates, time spent prescribing, user satisfaction, and reported workarounds. Initial data shows a significant reduction in legibility errors and dose errors, particularly in paediatrics. However, they also identify a new issue: an increase in 'alert fatigue' due to too many non-critical warnings. They then refine the system's alert thresholds and prioritise critical warnings.
• Continuous Improvement: Ongoing user feedback shapes future system updates, and the team regularly reviews national safety alerts to ensure the system’s clinical decision support remains current.

This example demonstrates how a systematic approach, combining technology, process redesign, and cultural adaptation, addresses the root causes of errors, leading to sustainable safety improvements.

How Lazomis can help

Lazomis provides a suite of tools that can support various stages of implementing a systems approach to medicines safety:

• QI Project Setup: Structure your medicines safety improvement initiatives from conception to completion, capturing aims, measures, changes, and key stakeholders.
• Data Collection & Analysis: Utilise customisable forms and dashboards to collect and visualise local medicines safety incident data, identify trends, and track the impact of interventions over time.
• Process Mapping Tools: Digitally map current medication pathways to identify bottlenecks, redundant steps, and potential failure points, informing process redesign efforts.
• Knowledge Hub: Access and share best practices, guidelines, and safety alerts derived from national bodies directly within your project workspace, ensuring your team is working with current, evidence-informed approaches.
• Reporting & Communication: Generate clear, concise reports on project progress and outcomes for governance committees, staff briefings, and local audit requirements.

This resource supports, but does not replace, clinical judgement. Local policy, formulary and specialist advice should be followed.

Key takeaways